Abstract

BackgroundMany kidney allografts fail due to the occurrence of antibody-mediated rejection (ABMR), related to donor-specific anti-HLA antibodies (HLA-DSA). However, the histology of ABMR can also be observed in patients without HLA-DSA. While some non-HLA antibodies have been related to the histology of ABMR, it is not well known to what extent they contribute to kidney allograft injury. Here we aimed to investigate the role of 82 different non-HLA antibodies in the occurrence of histology of ABMR after kidney transplantation.MethodsWe included all patients who underwent kidney transplantation between 2004-2013 in a single center and had biobanked serum. Pre- and post-transplant sera (n=2870) were retrospectively tested for the presence of 82 different non-HLA antibodies using a prototype bead assay on Luminex (Immucor, Inc). A ratio was calculated between the measured MFI value and the cut-off MFI defined by the vendor for each non-HLA target.Results874 patients had available pretransplant sera and were included in this analysis. Of them, 133 (15.2%) received a repeat kidney allograft, and 100 (11.4%) had pretransplant HLA-DSA. In total, 204 (23.3%) patients developed histology of ABMR after kidney transplantation. In 79 patients (38.7%) the histology of ABMR was explained by pretransplant or de novo HLA-DSA. The multivariable Cox analysis revealed that only the broadly non-HLA sensitized (number of positive non-HLA antibodies) patients and those with the highest total strength of the non-HLA antibodies (total ratios of the positive non-HLA antibodies) were independently associated with increased rates of histology of ABMR after transplantation. Additionally, independent associations were found for antibodies against TUBB (HR=2.40; 95% CI 1.37 – 4.21, p=0.002), Collagen III (HR=1.67; 95% CI 1.08 – 2.58, p=0.02), VCL (HR=2.04; 95% CI 1.12 – 3.71, p=0.02) and STAT6 (HR=1.47; 95% CI 1.01 – 2.15, p=0.04). The overall posttransplant non-HLA autoreactivity was not associated with increased rates of ABMRh.ConclusionsThis study shows that patients highly and broadly sensitized against non-HLA targets are associated with an increased risk of ABMR histology after kidney transplantations in the absence of HLA-DSA. Also, some pretransplant non‐HLA autoantibodies are individually associated with increased rates of ABMR histology. However, whether these associations are clinically relevant and represent causality, warrants further studies.

Highlights

  • Many kidney allografts fail due to the occurrence of antibodymediated rejection (ABMR) and donor-specific anti-HLA antibodies (HLA-DSA) [1]

  • In a large cohort of 934 kidney transplant recipients, this study shows that a high degree of pretransplant non-HLA autoantibody burden is independently associated with increased rates of developing ABMR histology (ABMRh) in the absence of HLA-DSA

  • The overall posttransplant non-HLA autoreactivity was not associated with increased rates of ABMRh, and no associations were observed between the presence of non-HLA autoantibodies and transplant glomerulopathy or graft failure

Read more

Summary

Introduction

Many kidney allografts fail due to the occurrence of antibodymediated rejection (ABMR) and donor-specific anti-HLA antibodies (HLA-DSA) [1]. The role of antibody responses against non-HLA targets in mediating ABMR has become a central focus in kidney transplantation in the latest years [7]. While the number of publications linking non-HLA antibodies to the development of ABMR histology (ABMRh) is growing, it is still unclear how these non-HLA antibodies contribute to kidney allograft damage and graft failure. It has been shown that in patients with HLA-DSA, the concomitant presence of antibodies, anti-AT1R or anti-ARHGDIB, portends inferior kidney graft outcome suggesting a synergistic effect of these antibodies on allograft injury [18, 20]. Many kidney allografts fail due to the occurrence of antibody-mediated rejection (ABMR), related to donor-specific anti-HLA antibodies (HLA-DSA). We aimed to investigate the role of 82 different non-HLA antibodies in the occurrence of histology of ABMR after kidney transplantation

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.